Am J Physiol Cell Physiol  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (September 30, 2009). doi:10.1152/ajpcell.00184.2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Yoo, J.
Right arrow Articles by Rozengurt, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoo, J.
Right arrow Articles by Rozengurt, E.

Research Article

Protein kinase D mediates synergistic expression of COX-2 induced by TNF-{alpha} and bradykinin in human colonic myofibroblasts

James Yoo,1 Christine Chung,1 Lee Warren Slice,2 James Sinnett-Smith,1 and Enrique Rozengurt1,*

1David Geffen School of Medicine at UCLA 2UCLA

Submitted 29 April 2009 ; revised 17 September 2009 ; accepted in final form 28 September 2009

Myofibroblasts have recently been identified as major mediators of tumor necrosis factor-{alpha} (TNF-{alpha})-associated colitis but the precise mechanism(s) involved remains incompletely understood. In particular, the possibility that TNF-{alpha} signaling cross talks with other pro-inflammatory mediators, including bradykinin (BK), has not been examined in these cells. Here, we show that treatment of 18Co cells, a model of human colonic myofibroblasts, with BK and TNF-{alpha} induce striking synergistic COX-2 protein expression that was paralleled by increases in the levels of transcripts encoding COX-2 and m-PGES-1 and by the production of PGE2. COX-2 expression in 18Co cells treated with BK and TNF-{alpha} was prevented by the B2 BK receptor antagonist HOE140, the preferential protein kinase C (PKC) inhibitors Ro31-8220 and GF109203X, and Go6976, an inhibitor of conventional PKCs and protein kinase D (PKD). In a parallel fashion, TNF-{alpha}, while having no detectable effect on the activation of PKD when added alone, augmented PKD activation induced by BK, as measured by PKD phosphorylation at its activation loop (Ser744) and auto-phosphorylation site (Ser916). BK-induced PKD activation was also inhibited by HOE140, Ro31-8220, and Go6976. Transfection of 18Co cells with siRNA targeting PKD completely inhibited the synergistic increase in COX-2 protein in response to BK and TNF-{alpha} demonstrating, for the first time, a critical role of PKD in the pathways leading to synergistic expression of COX-2. Our results imply that cross talk between TNF-{alpha} and BK amplifies a PKD phosphorylation cascade that mediates synergistic COX-2 expression in colonic myofibroblasts. It is plausible that PKD increases COX-2 expression in colonic myofibroblasts to promote an inflammatory microenvironment that supports tumor growth.

PKC; 18Co Cells; PGE2; PKD phosphorylation



* David Geffen School of Medicine at UCLA erozengurt{at}mednet.ucla.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.